With the opening of a new £17m plant, Klinge Pharma invested in vital quality control and particle sizing operations for a range of solid-dose medicines.

With the opening of a new £17m plant, Klinge Pharma invested in vital quality control and particle sizing operations for a range of solid-dose medicines. Having worked with Russell Finex to supply units for an existing facility, Russell Finex were recognized as setting the standard for the pharmaceutical industry, and were the natural choice to supply units for the new plant.

Two Russell Compact Sieves^® were provided incorporating twin high-frequency vibrators to check screen incoming dry raw materials and remove any lumps that may have formed during transportation. At a later stage, two double-deck 1,200mm Russell Europa sieves are employed to segregate powders into different particle sizes, ready for further processing. At the final product coating, two 700mm Russell Europa sieves are used to sieve out any agglomerated particles.